 Ondansetron high-dose metoclopramide prophylaxis acute cisplatin-induced nausea vomiting multicenter double-blind crossover study OBJECTIVE efficacy side effects ondansetron high-dose metoclopramide acute cisplatin-induced nausea vomiting DESIGN double-blind crossover trial SETTING university hospitals cancer institute community hospitals PATIENTS patients evaluable acute phase delayed phase Major reasons evaluable second course patients protocol violation patients change cisplatin dose patients acute phase rescue medication day patients protocol violation patients inadequate data patients delayed phase INTERVENTIONS patients cisplatin body area median none chemotherapy Thirty minutes cisplatin administration ondansetron minutes dose mg continuous infusion mg/h hours Metoclopramide dose mg/kg body weight continuous infusion hours mg/kg delayed phase days first oral dose infusion oral dose metoclopramide mg times ondansetron mg times days MEASUREMENTS MAIN RESULTS acute phase major complete response ondansetron-treated metoclopramide-treated patients Nausea ondansetron-treated patients delayed phase significant difference ondansetron- metoclopramide-treated patients Nausea metoclopramide CONCLUSIONS Ondansetron effective acute nausea vomiting delayed phase results drugs metoclopramide effect delayed nausea superior Patients preferred ondansetron